Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Ebola virus

This page shows the latest Ebola virus news and features for those working in and with pharma, biotech and healthcare.

Regeneron scores first FDA approval for Ebola antibody treatment

Regeneron scores first FDA approval for Ebola antibody treatment

The US Food and Drug Administration (FDA) has approved Regeneron’s Inmazeb, making it the first FDA-approved treatment for the Ebola virus in adults and children. ... Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) is a mixture of three

Latest news

  • AbbVie, Amgen and Takeda team up for joint COVID-19 trial AbbVie, Amgen and Takeda team up for joint COVID-19 trial

    This includes Gilead’s investigational antiviral drug remdesivir, which the company had originally been evaluating as a treatment for Ebola virus disease. ... Unfortunately, not all efforts to repurpose drugs have proved successful, with AbbVie’s

  • J&J says COVID-19 vaccine could be ready in early 2021 J&J says COVID-19 vaccine could be ready in early 2021

    which have already been deployed to make vaccines for Ebola, Zika, HIV and respiratory syncytial virus (RSV) candidates. ... During the Ebola virus epidemic in West Africa, J&J’s Janssen unit used the platforms to produce more than two million vaccine

  • UPDATED: Gilead drops remdesivir’s orphan drug designation UPDATED: Gilead drops remdesivir’s orphan drug designation

    It added that it is “making significant at-risk investments to develop and manufacture” the drug as the virus spreads at a rapid rate not only in the US, but across ... Remdesivir, originally developed as a treatment for Ebola virus disease, has been

  • Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

    The drug, which health experts from the World Health Organization (WHO) said is one of the most promising candidates against the virus, is currently being studied across two trials in China, ... Prior to the novel coronavirus outbreak, Gilead was

  • Moderna and GSK advance coronavirus vaccine candidates Moderna and GSK advance coronavirus vaccine candidates

    Aside from vaccines, Gilead has offered its investigational antiviral drug remdesivir for clinical trials in China – the drug has been identified as showing promise against the virus, and will be evaluated ... The drug was originally being developed as

More from news
Approximately 3 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Scientists have since industrialised the concept, leading to the development of antibodies against Ebola and respiratory syncytial virus. ... The same platform underpins CanSino’s Ebola vaccine that won approval in China in 2017.

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    Prior to the coronavirus outbreak, Gilead had primarily been focused on testing remdesivir’s potential in Ebola virus disease, although the antiviral also demonstrated promise in other coronaviruses, including severe acute ... This is particularity

  • Communicating in a crisis Communicating in a crisis

    Nobody working in the healthcare world has been able to ignore the outbreak of the Ebola virus in West Africa this past year. ... Timeline of Ebola outbreak in West Africa. December 2013. Two-year-old child contracts Ebola virus in Guinea.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Cool heads in a crisis?

    First there was Ebola and now there is Zika; two official World Health Organization (WHO) Public Health Emergencies of International Concern (PHEIC) within as many years.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...

Quick links